• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒长度与多发性骨髓瘤骨髓间充质干细胞中IL-6和MIP-1α的表达呈正相关。

Telomere length is positively associated with the expression of IL‑6 and MIP‑1α in bone marrow mesenchymal stem cells of multiple myeloma.

作者信息

Li Shengli, Jiang Yang, Li Ai, Liu Xiaoli, Xing Xiangling, Guo Yanan, Xu Yaqi, Hao Yunliang, Zheng Chengyun

机构信息

Department of Hematology, The Second Hospital, Institute of Biotherapy for Hematological Malignancies, Shandong University, Jinan, Shandong 250033, P.R. China.

Department of Hematology, Jining No. 1 People's Hospital, Jining, Shandong 272100, P.R. China.

出版信息

Mol Med Rep. 2017 Sep;16(3):2497-2504. doi: 10.3892/mmr.2017.6885. Epub 2017 Jun 29.

DOI:10.3892/mmr.2017.6885
PMID:28677723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5547952/
Abstract

Potential roles of mesenchymal stem cells (MSCs) in the pathogenesis of multiple myeloma (MM) are largely unknown. In the current study, the authors analyzed telomere length and the expressions of interleukin (IL)‑6 and macrophage inflammatory protein (MIP)‑1α in MSCs derived from the bone marrow (BM) of MM patients and controls. The current results demonstrated that there was no significant difference in cell surface expression of CD73 and CD90, and the capacity to differentiate into bone tissue were identified between the BM MSCs derived from MM patients and controls. Interestingly, telomere length (TL) and mRNA expressions of IL‑6 and MIP‑1α were significantly longer or higher in BM MSCs of MM than those of controls. Moreover, TL is positively associated with the expressions of IL‑6 and MIP‑1α at the mRNA level in BM MSCs of MM. Additionally, IL‑6 and MIP‑1α expression were significantly upregulated when MSCs from MM patients were cultured in the myeloma associated condition medium. The present study indicated that myeloma‑associated elongation of TL of BM MSCs may be a key element contributing to the increased IL‑6 and MIP‑1α expression, by which MSCs in the tumor microenvironment may facilitate MM and/or MM bone disease development.

摘要

间充质干细胞(MSCs)在多发性骨髓瘤(MM)发病机制中的潜在作用在很大程度上尚不清楚。在当前研究中,作者分析了多发性骨髓瘤患者和对照组骨髓(BM)来源的间充质干细胞中端粒长度以及白细胞介素(IL)-6和巨噬细胞炎性蛋白(MIP)-1α的表达。当前结果表明,多发性骨髓瘤患者和对照组来源的骨髓间充质干细胞在CD73和CD90的细胞表面表达以及分化为骨组织的能力方面没有显著差异。有趣的是,多发性骨髓瘤患者骨髓间充质干细胞的端粒长度(TL)以及IL-6和MIP-1α的mRNA表达明显长于或高于对照组。此外,在多发性骨髓瘤患者骨髓间充质干细胞中,端粒长度在mRNA水平上与IL-6和MIP-1α的表达呈正相关。另外,当将多发性骨髓瘤患者的间充质干细胞在骨髓瘤相关条件培养基中培养时,IL-6和MIP-1α表达显著上调。本研究表明,骨髓瘤相关的骨髓间充质干细胞端粒长度延长可能是导致IL-6和MIP-1α表达增加的关键因素,肿瘤微环境中的间充质干细胞可能通过这一机制促进多发性骨髓瘤和/或多发性骨髓瘤骨病的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/b950be5c2755/MMR-16-03-2497-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/fdb2e8039904/MMR-16-03-2497-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/b7ac88ad843a/MMR-16-03-2497-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/d6bb32db4df6/MMR-16-03-2497-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/47444d0568fe/MMR-16-03-2497-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/b950be5c2755/MMR-16-03-2497-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/fdb2e8039904/MMR-16-03-2497-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/b7ac88ad843a/MMR-16-03-2497-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/d6bb32db4df6/MMR-16-03-2497-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/47444d0568fe/MMR-16-03-2497-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1d/5547952/b950be5c2755/MMR-16-03-2497-g04.jpg

相似文献

1
Telomere length is positively associated with the expression of IL‑6 and MIP‑1α in bone marrow mesenchymal stem cells of multiple myeloma.端粒长度与多发性骨髓瘤骨髓间充质干细胞中IL-6和MIP-1α的表达呈正相关。
Mol Med Rep. 2017 Sep;16(3):2497-2504. doi: 10.3892/mmr.2017.6885. Epub 2017 Jun 29.
2
[Biological properties of mesenchymal stem cells derived from bone marrow of patients with multiple myeloma].[多发性骨髓瘤患者骨髓来源间充质干细胞的生物学特性]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Dec;14(6):1138-42.
3
In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.来自多发性骨髓瘤患者的间充质干细胞的体外迁移异常仅部分受硼替佐米调节。
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6705-15. eCollection 2014.
4
Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.多发性骨髓瘤与骨髓间充质干细胞的相互作用:对翻译起始的影响
Mol Carcinog. 2016 Sep;55(9):1343-54. doi: 10.1002/mc.22378. Epub 2015 Aug 21.
5
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.多发性骨髓瘤衍生的锯齿状配体增加骨髓微环境中的自分泌和旁分泌白细胞介素-6表达。
Oncotarget. 2016 Aug 30;7(35):56013-56029. doi: 10.18632/oncotarget.10820.
6
Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma.多发性骨髓瘤患者来源的骨髓间充质干细胞的表型和功能特征
Leukemia. 2007 Jan;21(1):158-63. doi: 10.1038/sj.leu.2404466. Epub 2006 Nov 9.
7
Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.源自正常和多发性骨髓瘤骨髓间充质干细胞的微泡对骨髓瘤细胞的表型和翻译起始有不同的调节作用。
Carcinogenesis. 2017 Jul 1;38(7):708-716. doi: 10.1093/carcin/bgx045.
8
Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.骨髓间充质基质细胞在骨髓增生异常综合征和多发性骨髓瘤中的常见和不同改变。
Cell Prolif. 2020 May;53(5):e12819. doi: 10.1111/cpr.12819. Epub 2020 May 5.
9
Anti-cancer effects of Staphylococcal Enterotoxin type B on U266 cells co-cultured with Mesenchymal Stem Cells.金黄色葡萄球菌肠毒素 B 对与间充质干细胞共培养的 U266 细胞的抗癌作用。
Microb Pathog. 2017 Dec;113:438-444. doi: 10.1016/j.micpath.2017.11.024. Epub 2017 Nov 21.
10
Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.骨髓间充质基质细胞被多发性骨髓瘤细胞产生的趋化因子 CCL25 吸引,并有利于骨髓瘤细胞在体外和体内的生长。
Stem Cells. 2012 Feb;30(2):266-79. doi: 10.1002/stem.787.

引用本文的文献

1
Rebuilding the microenvironment of primary tumors in humans: a focus on stroma.重建人类原发性肿瘤的微环境:以基质为重点。
Exp Mol Med. 2024 Mar;56(3):527-548. doi: 10.1038/s12276-024-01191-5. Epub 2024 Mar 5.
2
Associations of genetically predicted circulating levels of cytokines with telomere length: a Mendelian randomization study.基于孟德尔随机化研究的细胞因子循环水平的遗传预测与端粒长度的相关性。
Front Immunol. 2023 Oct 24;14:1276257. doi: 10.3389/fimmu.2023.1276257. eCollection 2023.
3
Prognostic significance of dysregulation of shelterin complex and its correlation with telomere length and cytogenetics in multiple myeloma.

本文引用的文献

1
Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.硼替佐米介导的端粒酶下调和端粒稳态破坏促成恶性细胞凋亡。
Oncotarget. 2015 Nov 10;6(35):38079-92. doi: 10.18632/oncotarget.5752.
2
Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.在DLK1-DIO3基因组区域的参与下,多发性骨髓瘤细胞改变骨髓间充质基质细胞的衰老表型。
BMC Cancer. 2015 Feb 18;15:68. doi: 10.1186/s12885-015-1078-3.
3
Pathogenesis beyond the cancer clone(s) in multiple myeloma.
端粒保护蛋白复合体失调在多发性骨髓瘤中的预后意义及其与端粒长度和细胞遗传学的相关性
J Genet Eng Biotechnol. 2023 May 3;21(1):50. doi: 10.1186/s43141-023-00504-x.
4
Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression.多发性骨髓瘤中的骨髓间充质基质细胞:它们作为骨髓瘤进展的积极促成因素的作用
Cancers (Basel). 2021 May 22;13(11):2542. doi: 10.3390/cancers13112542.
5
Aging of Bone Marrow Mesenchymal Stromal Cells: Hematopoiesis Disturbances and Potential Role in the Development of Hematologic Cancers.骨髓间充质基质细胞衰老:造血紊乱及其在血液系统恶性肿瘤发生中的潜在作用
Cancers (Basel). 2020 Dec 29;13(1):68. doi: 10.3390/cancers13010068.
6
Current Understanding of Myelomatous Mesenchymal Stromal Cells Extended through Advances in Experimental Methods.通过实验方法的进展扩展了对骨髓瘤间充质基质细胞的当前认识。
Cancers (Basel). 2020 Dec 23;13(1):25. doi: 10.3390/cancers13010025.
7
Osteoblast suppression in multiple myeloma bone disease.多发性骨髓瘤骨病中的成骨细胞抑制
J Bone Oncol. 2018 Sep 15;13:62-70. doi: 10.1016/j.jbo.2018.09.001. eCollection 2018 Nov.
8
Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?多发性骨髓瘤中的间充质干细胞:治疗工具还是治疗靶点?
Leukemia. 2018 Jul;32(7):1500-1514. doi: 10.1038/s41375-018-0061-9. Epub 2018 Feb 22.
多发性骨髓瘤中癌症克隆之外的发病机制。
Blood. 2015 May 14;125(20):3049-58. doi: 10.1182/blood-2014-11-568881. Epub 2015 Apr 2.
4
Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells.多发性骨髓瘤骨髓间充质基质细胞中的免疫损伤
Cancer Immunol Immunother. 2015 Feb;64(2):213-24. doi: 10.1007/s00262-014-1623-y. Epub 2014 Oct 24.
5
The bone marrow stromal compartment in multiple myeloma patients retains capability for osteogenic differentiation in vitro: defining the stromal defect in myeloma.多发性骨髓瘤患者的骨髓基质隔室在体外保留成骨分化的能力:定义骨髓瘤中的基质缺陷。
Br J Haematol. 2014 Oct;167(2):194-206. doi: 10.1111/bjh.13020. Epub 2014 Jul 31.
6
Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients.miR-135b的上调参与了多发性骨髓瘤患者来源的间充质干细胞成骨分化受损的过程。
PLoS One. 2013 Nov 6;8(11):e79752. doi: 10.1371/journal.pone.0079752. eCollection 2013.
7
Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.骨髓瘤浆细胞通过刺激间充质基质细胞的增殖来改变骨髓微环境。
Haematologica. 2014 Jan;99(1):163-71. doi: 10.3324/haematol.2013.090977. Epub 2013 Aug 9.
8
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.骨髓间充质基质细胞衍生的外泌体促进多发性骨髓瘤进展。
J Clin Invest. 2013 Apr;123(4):1542-55. doi: 10.1172/JCI66517.
9
Telomere length analysis of human mesenchymal stem cells by quantitative PCR.采用实时定量 PCR 技术分析人骨髓间充质干细胞端粒长度。
Gene. 2013 May 1;519(2):348-55. doi: 10.1016/j.gene.2013.01.039. Epub 2013 Feb 1.
10
Bone marrow microenvironment in multiple myeloma progression.多发性骨髓瘤进展中的骨髓微环境
J Biomed Biotechnol. 2012;2012:157496. doi: 10.1155/2012/157496. Epub 2012 Oct 3.